237 related articles for article (PubMed ID: 27592446)
1. Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab.
Adami G; Rossini M; Gatti D; Orsolini G; Idolazzi L; Viapiana O; Scarpa A; Canalis E
Bone; 2016 Nov; 92():150-156. PubMed ID: 27592446
[TBL] [Abstract][Full Text] [Related]
2. Hajdu-Cheney syndrome: a review.
Canalis E; Zanotti S
Orphanet J Rare Dis; 2014 Dec; 9():200. PubMed ID: 25491639
[TBL] [Abstract][Full Text] [Related]
3. A mutation in NOTCH2 gene first associated with Hajdu-Cheney syndrome in a Greek family: diversity in phenotype and response to treatment.
Efstathiadou ZA; Kostoulas C; Polyzos SA; Adamidou F; Georgiou I; Kita M
Endocrine; 2021 Jan; 71(1):208-215. PubMed ID: 32772338
[TBL] [Abstract][Full Text] [Related]
4. Hajdu-Cheney Syndrome, a Disease Associated with NOTCH2 Mutations.
Canalis E; Zanotti S
Curr Osteoporos Rep; 2016 Aug; 14(4):126-31. PubMed ID: 27241678
[TBL] [Abstract][Full Text] [Related]
5. Clinical and experimental aspects of notch receptor signaling: Hajdu-Cheney syndrome and related disorders.
Canalis E
Metabolism; 2018 Mar; 80():48-56. PubMed ID: 28941602
[TBL] [Abstract][Full Text] [Related]
6. High Bone Turnover in Mice Carrying a Pathogenic Notch2 Mutation Causing Hajdu-Cheney Syndrome.
Vollersen N; Hermans-Borgmeyer I; Cornils K; Fehse B; Rolvien T; Triviai I; Jeschke A; Oheim R; Amling M; Schinke T; Yorgan TA
J Bone Miner Res; 2018 Jan; 33(1):70-83. PubMed ID: 28856714
[TBL] [Abstract][Full Text] [Related]
7. A novel NOTCH2 mutation identified in a Korean family with Hajdu-Cheney syndrome showing phenotypic diversity.
Han MS; Ko JM; Cho TJ; Park WY; Cheong HI
Ann Clin Lab Sci; 2015; 45(1):110-4. PubMed ID: 25696021
[TBL] [Abstract][Full Text] [Related]
8. An Antibody to Notch2 Reverses the Osteopenic Phenotype of Hajdu-Cheney Mutant Male Mice.
Canalis E; Sanjay A; Yu J; Zanotti S
Endocrinology; 2017 Apr; 158(4):730-742. PubMed ID: 28323963
[TBL] [Abstract][Full Text] [Related]
9. Hajdu Cheney Mouse Mutants Exhibit Osteopenia, Increased Osteoclastogenesis, and Bone Resorption.
Canalis E; Schilling L; Yee SP; Lee SK; Zanotti S
J Biol Chem; 2016 Jan; 291(4):1538-1551. PubMed ID: 26627824
[TBL] [Abstract][Full Text] [Related]
10. Mutations in NOTCH2 in patients with Hajdu-Cheney syndrome.
Zhao W; Petit E; Gafni RI; Collins MT; Robey PG; Seton M; Miller KK; Mannstadt M
Osteoporos Int; 2013 Aug; 24(8):2275-81. PubMed ID: 23389697
[TBL] [Abstract][Full Text] [Related]
11. NOTCH2 Hajdu-Cheney Mutations Escape SCF
Fukushima H; Shimizu K; Watahiki A; Hoshikawa S; Kosho T; Oba D; Sakano S; Arakaki M; Yamada A; Nagashima K; Okabe K; Fukumoto S; Jimi E; Bigas A; Nakayama KI; Nakayama K; Aoki Y; Wei W; Inuzuka H
Mol Cell; 2017 Nov; 68(4):645-658.e5. PubMed ID: 29149593
[TBL] [Abstract][Full Text] [Related]
12. Clinical consequences in truncating mutations in exon 34 of NOTCH2: report of six patients with Hajdu-Cheney syndrome and a patient with serpentine fibula polycystic kidney syndrome.
Narumi Y; Min BJ; Shimizu K; Kazukawa I; Sameshima K; Nakamura K; Kosho T; Rhee Y; Chung YS; Kim OH; Fukushima Y; Park WY; Nishimura G
Am J Med Genet A; 2013 Mar; 161A(3):518-26. PubMed ID: 23401378
[TBL] [Abstract][Full Text] [Related]
13. The Hajdu Cheney mutation sensitizes mice to the osteolytic actions of tumor necrosis factor α.
Yu J; Canalis E
J Biol Chem; 2019 Sep; 294(39):14203-14214. PubMed ID: 31371452
[TBL] [Abstract][Full Text] [Related]
14. Sustained Notch2 signaling in osteoblasts, but not in osteoclasts, is linked to osteopenia in a mouse model of Hajdu-Cheney syndrome.
Zanotti S; Yu J; Sanjay A; Schilling L; Schoenherr C; Economides AN; Canalis E
J Biol Chem; 2017 Jul; 292(29):12232-12244. PubMed ID: 28592489
[TBL] [Abstract][Full Text] [Related]
15. Bone Structural Characteristics and Response to Bisphosphonate Treatment in Children With Hajdu-Cheney Syndrome.
Sakka S; Gafni RI; Davies JH; Clarke B; Tebben P; Samuels M; Saraff V; Klaushofer K; Fratzl-Zelman N; Roschger P; Rauch F; Högler W
J Clin Endocrinol Metab; 2017 Nov; 102(11):4163-4172. PubMed ID: 28938420
[TBL] [Abstract][Full Text] [Related]
16. Exploratory use of romosozumab for osteoporosis in a patient with Hajdu-Cheney syndrome: a case report.
Kim KJ; Hong N; Lee S; Shin S; Rhee Y
Osteoporos Int; 2023 May; 34(5):1005-1009. PubMed ID: 36622389
[TBL] [Abstract][Full Text] [Related]
17. Severe osteoporosis and mutation in NOTCH2 gene in a woman with Hajdu-Cheney syndrome.
Stathopoulos IP; Trovas G; Lampropoulou-Adamidou K; Koromila T; Kollia P; Papaioannou NA; Lyritis G
Bone; 2013 Jan; 52(1):366-71. PubMed ID: 23117206
[TBL] [Abstract][Full Text] [Related]
18. Oral Surgery Procedures in a Patient with Hajdu-Cheney Syndrome Treated with Denosumab-A Rare Case Report.
Kaczoruk-Wieremczuk M; Adamska P; Adamski ŁJ; Wychowański P; Jereczek-Fossa BA; Starzyńska A
Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501688
[TBL] [Abstract][Full Text] [Related]
19. Mice harboring a Hajdu Cheney Syndrome mutation are sensitized to osteoarthritis.
Zanotti S; Yu J; Bridgewater D; Wolf JM; Canalis E
Bone; 2018 Sep; 114():198-205. PubMed ID: 29940267
[TBL] [Abstract][Full Text] [Related]
20. Serpentine fibula-polycystic kidney syndrome caused by truncating mutations in NOTCH2.
Isidor B; Le Merrer M; Exner GU; Pichon O; Thierry G; Guiochon-Mantel A; David A; Cormier-Daire V; Le Caignec C
Hum Mutat; 2011 Nov; 32(11):1239-42. PubMed ID: 21793104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
